mRNA Vaccine Candidate BNT162b2 Shows Promise; Recommended for Large-Scale Trials
...was used to select the final vaccine candidate, BNT162b2, as well as comparison of the safety and immun…
Showing results for 'bnt162b2'
BioNTech & Pfizer’s BNT162b2 Now Under Rolling Submission Status by EMA: Means COVID-19 Vaccine Could Get Approved Faster
...sets and all else goes well, the actual registration and marketing authorization of the BNT162b2 vaccin…
Pfizer Vaccine (BNT162b2) May Trigger the Shingles at Least in People with Rheumatic Conditions
Recently, a healthy TrialSite colleague in his mid-50s received the BNT162b2 vaccine and the jab triggered…
Independent Physicians Group in Dayton Serves as Trial Site for BNT162b2 (Pfizer) COVID-19 Vaccine Trial
PriMed Medical Research has already administered the BNT162b2 COVID-19 vaccine candidate to what is report…
University Hospitals Ready Initiation of BNT162b2 Phase 2/3 COVID-19 Vaccine Trial Next Week: Seeking Minority Participation
...evaluating the mRNA-based BNT162 program (actually represents now five therapies for which BNT162b2 wil…
Reports out of Ireland that Pfizer/BioNTech’s BNT162b2 Very Close to FDA & EMA EUA
...million doses of BNT162b2 before the end of 2020. he vaccine candidate has been tested on 35,000 people…
European Commission Inks Deal with Pfizer/BioNTech for up to 300m Doses of BNT162b2
The European Commission approved a contract with BioNTech and Pfizer involving the initial purchase of 200 million doses of…
Pfizer’s BNT162b2 COVID-19 Vaccine Phase 2/3 Clinical Trial Comes to University Hospitals Cleveland Medical Center
...the investigational vaccine called BNT162b2, against SARS-CoV-2. UH’s study site is one of approx…
Canada Implements Plan B: Embraces Project LightSpeed Securing Access to BNT162 & Mitigating Risk Associated with Ad5-nCoV
...regulators, the companies selected the BNT162b2 vaccine candidate to move forward into a Phase 2/3 stud…
Tel Aviv University & Clatit Study Reveals South African Variant may ‘Break’ BNT62b2, Meanwhile Israel Heads out of Pandemic
...1% of all COVID-19 cases, in the study population can actually “break through” the mRNA-based vaccine called…